ADAMTS13 and chronic thromboembolic pulmonary hypertension: Other studies have shown that the dysregulation of ADAMTS13 and VWF levels is involved in diseases such as chronic thromboembolic pulmonary hypertension (25) and venous thromboembolism (26).